{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T11:42:02Z","timestamp":1794138122540,"version":"4.8.0"},"reference-count":40,"publisher":"American Society of Hematology","issue":"17","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,4,27]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>Two circulating exosomal microRNAs, let-7b and miR-18a, improved survival prediction in patients with MM. Circulating exosomal miRNAs enhanced the stratification of patients with high-risk factors.<\/jats:p>","DOI":"10.1182\/blood-2016-09-742296","type":"journal-article","created":{"date-parts":[[2017,2,17]],"date-time":"2017-02-17T20:40:22Z","timestamp":1487364022000},"page":"2429-2436","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":240,"title":["Prognostic role of circulating exosomal miRNAs in multiple myeloma"],"prefix":"10.1182","volume":"129","author":[{"given":"Salomon","family":"Manier","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;"},{"name":"Department of Hematology, University Hospital Center of Lille, Lille, France;"},{"name":"INSERM Unit\u00e9 Mixte de Recherche (UMR)-S1172, Lille 2 University, Lille, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Jen","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;"},{"name":"Division of Hematology and Oncology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan;"},{"name":"School of Medicine, National Yang-Ming University, Taipei, Taiwan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3050-0140","authenticated-orcid":false,"given":"Herv\u00e9","family":"Avet-Loiseau","sequence":"additional","affiliation":[{"name":"Laboratory for Genomics in Myeloma, INSERM Unit\u00e9 1037, Toulouse University Hospital, Toulouse, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihye","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0039-8800","authenticated-orcid":false,"given":"Jiantao","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Campigotto","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karma Z.","family":"Salem","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4633-4570","authenticated-orcid":false,"given":"Daisy","family":"Huynh","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siobhan V.","family":"Glavey","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley","family":"Rivotto","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Sacco","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;"},{"name":"Azienda Socio Sanitaria Territoriale (ASST) Spedali Civili di Brescia, Coordinamento e Progettazione Ricerca Clinica, Compressible-Fluid Dynamics for Renewable Energy Applications (CREA) Laboratory, Brescia, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo M.","family":"Roccaro","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;"},{"name":"Azienda Socio Sanitaria Territoriale (ASST) Spedali Civili di Brescia, Coordinamento e Progettazione Ricerca Clinica, Compressible-Fluid Dynamics for Renewable Energy Applications (CREA) Laboratory, Brescia, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Bouyssou","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Minvielle","sequence":"additional","affiliation":[{"name":"Center for Cancer Research Nantes-Angers, UMR-892 INSERM\u20136299 Centre National de la Recherche Scientifique, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Moreau","sequence":"additional","affiliation":[{"name":"Department of Hematology, University Hospital Center of Nantes, Nantes, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7705-8460","authenticated-orcid":false,"given":"Thierry","family":"Facon","sequence":"additional","affiliation":[{"name":"Department of Hematology, University Hospital Center of Lille, Lille, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Leleu","sequence":"additional","affiliation":[{"name":"Department of Hematology, University Hospital Center of Poitiers, Poitiers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edie","family":"Weller","sequence":"additional","affiliation":[{"name":"Laboratory for Genomics in Myeloma, INSERM Unit\u00e9 1037, Toulouse University Hospital, Toulouse, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Trippa","sequence":"additional","affiliation":[{"name":"Laboratory for Genomics in Myeloma, INSERM Unit\u00e9 1037, Toulouse University Hospital, Toulouse, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene M.","family":"Ghobrial","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"11","key":"2019111902525151400_B1","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJMra1011442","article-title":"Multiple myeloma","volume":"364","author":"Palumbo","year":"2011","journal-title":"N Engl J Med"},{"issue":"2","key":"2019111902525151400_B2","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/leu.2013.247","article-title":"IMWG consensus on risk stratification in multiple myeloma","volume":"28","author":"Chng","year":"2014","journal-title":"Leukemia"},{"issue":"15","key":"2019111902525151400_B3","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","article-title":"International staging system for multiple myeloma [published correction appears in J Clin Oncol. 2005;23(25):6281]","volume":"23","author":"Greipp","year":"2005","journal-title":"J Clin Oncol"},{"issue":"3","key":"2019111902525151400_B4","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/leu.2012.282","article-title":"Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma: an International Myeloma Working Group collaborative project","volume":"27","author":"Avet-Loiseau","year":"2013","journal-title":"Leukemia"},{"issue":"26","key":"2019111902525151400_B5","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1200\/JCO.2015.61.2267","article-title":"Revised International Staging System for Multiple Myeloma: a report from International Myeloma Working Group","volume":"33","author":"Palumbo","year":"2015","journal-title":"J Clin Oncol"},{"issue":"8","key":"2019111902525151400_B6","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nri855","article-title":"Exosomes: composition, biogenesis and function","volume":"2","author":"Th\u00e9ry","year":"2002","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"2019111902525151400_B7","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/nm.2753","article-title":"Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET","volume":"18","author":"Peinado","year":"2012","journal-title":"Nat Med"},{"issue":"4","key":"2019111902525151400_B8","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1172\/JCI66517","article-title":"BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression","volume":"123","author":"Roccaro","year":"2013","journal-title":"J Clin Invest"},{"issue":"5","key":"2019111902525151400_B9","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ccell.2014.09.005","article-title":"Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis","volume":"26","author":"Melo","year":"2014","journal-title":"Cancer Cell"},{"issue":"9","key":"2019111902525151400_B10","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrg2843","article-title":"The widespread regulation of microRNA biogenesis, function and decay","volume":"11","author":"Krol","year":"2010","journal-title":"Nat Rev Genet"},{"issue":"7043","key":"2019111902525151400_B11","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nature03702","article-title":"MicroRNA expression profiles classify human cancers","volume":"435","author":"Lu","year":"2005","journal-title":"Nature"},{"issue":"35","key":"2019111902525151400_B12","doi-asserted-by":"crossref","first-page":"12885","DOI":"10.1073\/pnas.0806202105","article-title":"MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis","volume":"105","author":"Pichiorri","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"2019111902525151400_B13","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/leu.2009.274","article-title":"Deregulation of microRNA expression in the different genetic subtypes of multiple myeloma and correlation with gene expression profiling","volume":"24","author":"Guti\u00e9rrez","year":"2010","journal-title":"Leukemia"},{"issue":"17","key":"2019111902525151400_B14","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1056\/NEJMoa050995","article-title":"A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia","volume":"353","author":"Calin","year":"2005","journal-title":"N Engl J Med"},{"issue":"3","key":"2019111902525151400_B15","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ccr.2006.01.025","article-title":"Unique microRNA molecular profiles in lung cancer diagnosis and prognosis","volume":"9","author":"Yanaihara","year":"2006","journal-title":"Cancer Cell"},{"issue":"1","key":"2019111902525151400_B16","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ccr.2007.12.008","article-title":"MicroRNA signature predicts survival and relapse in lung cancer","volume":"13","author":"Yu","year":"2008","journal-title":"Cancer Cell"},{"issue":"2","key":"2019111902525151400_B17","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S1470-2045(09)70343-2","article-title":"Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis","volume":"11","author":"Ueda","year":"2010","journal-title":"Lancet Oncol"},{"issue":"6","key":"2019111902525151400_B18","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1470-2045(12)70102-X","article-title":"Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis","volume":"13","author":"Liu","year":"2012","journal-title":"Lancet Oncol"},{"issue":"8","key":"2019111902525151400_B19","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nrclinonc.2011.76","article-title":"MicroRNAs in body fluids: the mix of hormones and biomarkers","volume":"8","author":"Cortez","year":"2011","journal-title":"Nat Rev Clin Oncol"},{"issue":"9","key":"2019111902525151400_B20","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/sj.leu.2404284","article-title":"International uniform response criteria for multiple myeloma","volume":"20","author":"Durie","year":"2006","journal-title":"Leukemia"},{"key":"2019111902525151400_B21","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/978-1-61779-068-3_15","article-title":"Exosome isolation for proteomic analyses and RNA profiling","volume":"728","author":"Taylor","year":"2011","journal-title":"Methods Mol Biol"},{"issue":"6","key":"2019111902525151400_B22","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1128\/JCM.02270-10","article-title":"Application of TaqMan low-density arrays for simultaneous detection of multiple respiratory pathogens","volume":"49","author":"Kodani","year":"2011","journal-title":"J Clin Microbiol"},{"key":"2019111902525151400_B23","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/978-1-61779-427-8_18","article-title":"miRNA expression profiling: from reference genes to global mean normalization","volume":"822","author":"D\u2019haene","year":"2012","journal-title":"Methods Mol Biol"},{"issue":"3","key":"2019111902525151400_B24","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nrclinonc.2014.5","article-title":"Clinical relevance of circulating cell-free microRNAs in cancer","volume":"11","author":"Schwarzenbach","year":"2014","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"2019111902525151400_B25","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3324\/haematol.2013.093500","article-title":"Circulating serum microRNAs as novel diagnostic and prognostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance","volume":"99","author":"Kubiczkova","year":"2014","journal-title":"Haematologica"},{"issue":"8","key":"2019111902525151400_B26","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1002\/ijc.29199","article-title":"Low serum miR-19a expression as a novel poor prognostic indicator in multiple myeloma","volume":"136","author":"Hao","year":"2015","journal-title":"Int J Cancer"},{"issue":"9","key":"2019111902525151400_B27","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1038\/leu.2014.155","article-title":"Circulating miRNA markers show promise as new prognosticators for multiple myeloma","volume":"28","author":"Rocci","year":"2014","journal-title":"Leukemia"},{"issue":"1","key":"2019111902525151400_B28","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.eururo.2014.07.035","article-title":"Exosomal miR-1290 and miR-375 as prognostic markers in castration-resistant prostate cancer","volume":"67","author":"Huang","year":"2015","journal-title":"Eur Urol"},{"issue":"7559","key":"2019111902525151400_B29","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature14581","article-title":"Glypican-1 identifies cancer exosomes and detects early pancreatic cancer","volume":"523","author":"Melo","year":"2015","journal-title":"Nature"},{"issue":"1","key":"2019111902525151400_B30","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.bbrc.2014.10.064","article-title":"U6 is not a suitable endogenous control for the quantification of circulating microRNAs","volume":"454","author":"Xiang","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"2019111902525151400_B31","doi-asserted-by":"crossref","first-page":"R64","DOI":"10.1186\/gb-2009-10-6-r64","article-title":"A novel and universal method for microRNA RT-qPCR data normalization","volume":"10","author":"Mestdagh","year":"2009","journal-title":"Genome Biol"},{"issue":"8","key":"2019111902525151400_B32","doi-asserted-by":"crossref","first-page":"e22988","DOI":"10.1371\/journal.pone.0022988","article-title":"Plasma miRNA as biomarkers for assessment of total-body radiation exposure dosimetry","volume":"6","author":"Cui","year":"2011","journal-title":"PLoS One"},{"issue":"10","key":"2019111902525151400_B33","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.tcb.2008.07.007","article-title":"The let-7 family of microRNAs","volume":"18","author":"Roush","year":"2008","journal-title":"Trends Cell Biol"},{"key":"2019111902525151400_B34","article-title":"The LIN28B\/let-7 axis is a novel therapeutic pathway in multiple myeloma [published online ahead of print 11 November 2016]","author":"Manier","journal-title":"Leukemia"},{"issue":"7","key":"2019111902525151400_B35","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/ng.392","article-title":"Lin28 promotes transformation and is associated with advanced human malignancies","volume":"41","author":"Viswanathan","year":"2009","journal-title":"Nat Genet"},{"issue":"11","key":"2019111902525151400_B36","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1038\/nsmb.2678","article-title":"Analysis of microRNA-target interactions across diverse cancer types","volume":"20","author":"Jacobsen","year":"2013","journal-title":"Nat Struct Mol Biol"},{"issue":"3","key":"2019111902525151400_B37","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.cell.2009.04.040","article-title":"SnapShot: MicroRNAs in cancer","volume":"137","author":"Spizzo","year":"2009","journal-title":"Cell"},{"issue":"2","key":"2019111902525151400_B38","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cell.2008.04.001","article-title":"miRiad roles for the miR-17-92 cluster in development and disease","volume":"133","author":"Mendell","year":"2008","journal-title":"Cell"},{"issue":"4","key":"2019111902525151400_B39","doi-asserted-by":"crossref","first-page":"R78","DOI":"10.1186\/bcr3693","article-title":"MicroRNA-18a inhibits hypoxia-inducible factor 1\u03b1 activity and lung metastasis in basal breast cancers","volume":"16","author":"Krutilina","year":"2014","journal-title":"Breast Cancer Res"},{"issue":"18","key":"2019111902525151400_B40","doi-asserted-by":"crossref","first-page":"25683","DOI":"10.18632\/oncotarget.8361","article-title":"Grapefruit-derived nanovectors deliver miR-18a for treatment of liver metastasis of colon cancer by induction of M1 macrophages","volume":"7","author":"Teng","year":"2016","journal-title":"Oncotarget"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/129\/17\/2429\/1399965\/blood742296.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/129\/17\/2429\/1399965\/blood742296.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T02:53:18Z","timestamp":1574131998000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/129\/17\/2429\/35954\/Prognostic-role-of-circulating-exosomal-miRNAs-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,27]]},"references-count":40,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2017,4,27]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2016-09-742296","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,27]]}}}